Related Experiment Video
Updated: Jul 6, 2026
03:20
Measuring Constipation in a Drosophila Model of Parkinson's Disease
Published on: September 22, 2023
Depressive symptoms in Parkinson's disease
1Department of Psychiatry, University of Kiel, Kiel, Germany. m.lemke@alsterdorf.de
European Journal of Neurology
|April 11, 2008
Summary
Depression affects nearly half of Parkinson's disease (PD) patients, impacting quality of life. Pramipexole shows promise as a first-line treatment for PD depression, improving mood and motor symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Movement Disorders
Background:
- Depression is prevalent in Parkinson's disease (PD), affecting ~45% of patients.
- Depression in PD is independent of motor deficits and significantly reduces quality of life.
- Anxiety and depression can precede motor symptoms, indicating a role in PD development.
Purpose of the Study:
- To review the role of depression in Parkinson's disease.
- To explore the efficacy of pramipexole in treating depression in PD patients.
Main Methods:
- Review of functional imaging studies and clinical investigations.
- Analysis of placebo-controlled studies on pramipexole's antidepressant effects.
- Evaluation of pramipexole's impact on both mood and motor symptoms in PD.
Main Results:
- Depression in PD is linked to serotonergic, noradrenergic, and dopaminergic mechanisms.
- Selective serotonin and noradrenaline reuptake inhibitors are effective and well-tolerated.
- Pramipexole demonstrated antidepressant effects in various depression forms and improved mood in PD patients.
Conclusions:
- Pramipexole may serve as a first-line treatment for Parkinson's disease patients experiencing depression.
- Effective management of depression is crucial for improving the quality of life in PD.
- Further research supports the use of pramipexole for comorbid depression and PD symptoms.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...